1-1 of 1
Julie Bergeron, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

Open Access
Clinical Trials & Observations
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Karim Laribi, Vladimir Ivanov, MD, Inho Kim, Jan Novak, Rebecca Champion, Walter Fiedler, Maria Pagoni, Julie Bergeron, MD, Stephen B Ting, Jing-Zhou Hou, Hematology Oncology, Takahiro Yamauchi, Jianxiang Wang, Stephen A. Strickland, Michael R. Savona, Tara L. Lin, Anoop K. Enjeti, Ing Soo Tiong, Sangmin Lee, Gail J Roboz, Relja Popovic, Qi Jiang, Zihuan Liu, Yan Sun, Wellington L Mendes, Brenda Chyla, Courtney D. DiNardo
Journal: Blood Advances
Blood Adv bloodadvances.2025017083.
https://doi.org/10.1182/bloodadvances.2025017083
Published: 2025
Includes: Supplemental data